• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

半乳糖凝集素-3是一种层粘连蛋白结合蛋白,无法调节人黑色素瘤细胞与层粘连蛋白的黏附。

Galectin-3, a laminin binding protein, fails to modulate adhesion of human melanoma cells to laminin.

作者信息

van den Brûle F A, Buicu C, Sobel M E, Liu F T, Castronovo V

机构信息

Metastasis Research Laboratory, University of Liège, Belgium.

出版信息

Neoplasma. 1995;42(5):215-9.

PMID:8552198
Abstract

Galectin-3 is a laminin binding protein which expression is altered in a variety of human carcinomas including colon, breast and endometrium. In these tumors, we consistently observed a down regulation of galectin-3 expression related to increased aggressiveness. Galectin-3 belongs to a family of galactose-binding lectins and binds laminin through its numerous poly-N-acetyllactosamine chains. To date, the exact role of galectin-3 in the complex interactions between cancer cells and laminin has not been clearly defined. Adhesion of melanoma cells to laminin is a critical event during tumor invasion and metastasis. In this study, we explore the possibility that galectin-3 could modulate attachment of two human melanoma cell lines to laminin. A2058 and A375 melanoma cell expressed galectin-3 on their surface as demonstrated by immunofluorescence, and attached to laminin in an in vitro assay. We demonstrate that neither recombinant galectin-3 nor an affinity purified antigalectin-3 antiserum altered adhesion of A2058 or A375 melanoma cells to laminin. Our data strongly suggest that galectin-3 is not a key element in adhesion of the melanoma cells to laminin. These results are not surprising in light of the observation that galectin-3 expression is down regulated in cancer and that increased adhesion to laminin is a constant feature of invasive cancer cells.

摘要

半乳糖凝集素-3是一种层粘连蛋白结合蛋白,其表达在包括结肠癌、乳腺癌和子宫内膜癌在内的多种人类癌症中发生改变。在这些肿瘤中,我们一致观察到半乳糖凝集素-3表达下调与侵袭性增加有关。半乳糖凝集素-3属于半乳糖结合凝集素家族,通过其众多的多聚-N-乙酰乳糖胺链与层粘连蛋白结合。迄今为止,半乳糖凝集素-3在癌细胞与层粘连蛋白之间复杂相互作用中的确切作用尚未明确界定。黑色素瘤细胞与层粘连蛋白的黏附是肿瘤侵袭和转移过程中的一个关键事件。在本研究中,我们探讨了半乳糖凝集素-3调节两种人类黑色素瘤细胞系与层粘连蛋白黏附的可能性。免疫荧光显示,A2058和A375黑色素瘤细胞在其表面表达半乳糖凝集素-3,并在体外试验中与层粘连蛋白黏附。我们证明,重组半乳糖凝集素-3和亲和纯化的抗半乳糖凝集素-3抗血清均未改变A2058或A375黑色素瘤细胞与层粘连蛋白的黏附。我们的数据强烈表明,半乳糖凝集素-3不是黑色素瘤细胞与层粘连蛋白黏附中的关键因素。鉴于观察到癌症中半乳糖凝集素-3表达下调且侵袭性癌细胞与层粘连蛋白的黏附增加是一个恒定特征,这些结果并不令人惊讶。

相似文献

1
Galectin-3, a laminin binding protein, fails to modulate adhesion of human melanoma cells to laminin.半乳糖凝集素-3是一种层粘连蛋白结合蛋白,无法调节人黑色素瘤细胞与层粘连蛋白的黏附。
Neoplasma. 1995;42(5):215-9.
2
Transglutaminase-mediated oligomerization of galectin-3 modulates human melanoma cell interactions with laminin.转谷氨酰胺酶介导的半乳糖凝集素-3寡聚化调节人黑素瘤细胞与层粘连蛋白的相互作用。
Cell Adhes Commun. 1998 Sep;5(6):425-35.
3
Adhesion of human breast carcinoma to extracellular matrix proteins is modulated by galectin-3.人乳腺癌与细胞外基质蛋白的黏附受半乳糖凝集素-3调控。
Invasion Metastasis. 1997;17(2):101-12.
4
Decreased expression of galectin-3 is associated with progression of human breast cancer.半乳糖凝集素-3表达降低与人类乳腺癌进展相关。
J Pathol. 1996 May;179(1):43-8. doi: 10.1002/(SICI)1096-9896(199605)179:1<43::AID-PATH541>3.0.CO;2-N.
5
Effects of the carbohydrate-binding protein galectin-3 on the invasiveness of human breast carcinoma cells.碳水化合物结合蛋白半乳糖凝集素-3对人乳腺癌细胞侵袭性的影响。
J Cell Physiol. 1996 Jul;168(1):51-8. doi: 10.1002/(SICI)1097-4652(199607)168:1<51::AID-JCP7>3.0.CO;2-7.
6
Carcinoembryonic antigen and other glycoconjugates act as ligands for galectin-3 in human colon carcinoma cells.癌胚抗原和其他糖缀合物在人结肠癌细胞中作为半乳糖凝集素-3的配体。
Cancer Res. 1995 May 15;55(10):2191-9.
7
Galectin-1 modulates human melanoma cell adhesion to laminin.
Biochem Biophys Res Commun. 1995 Apr 17;209(2):760-7. doi: 10.1006/bbrc.1995.1564.
8
Colon cancer mucin: a new ligand for the beta-galactoside-binding protein galectin-3.结肠癌黏蛋白:β-半乳糖苷结合蛋白半乳糖凝集素-3的一种新配体。
Cancer Res. 1996 Oct 1;56(19):4354-7.
9
Interactions between galectin-3 and Mac-2-binding protein mediate cell-cell adhesion.半乳糖凝集素-3与Mac-2结合蛋白之间的相互作用介导细胞间黏附。
Cancer Res. 1996 Oct 1;56(19):4530-4.
10
Galectin-3 promotes adhesion of human neutrophils to laminin.半乳糖凝集素-3促进人类中性粒细胞与层粘连蛋白的黏附。
J Immunol. 1996 May 15;156(10):3939-44.

引用本文的文献

1
Multifaceted roles of Galectins: from carbohydrate binding to targeted cancer therapy.半乳糖凝集素的多方面作用:从碳水化合物结合到靶向癌症治疗。
Biomark Res. 2025 Mar 25;13(1):49. doi: 10.1186/s40364-025-00759-1.
2
Novel Galectin-3 Roles in Neurogenesis, Inflammation and Neurological Diseases.新型半乳糖凝集素-3在神经发生、炎症和神经疾病中的作用
Cells. 2021 Nov 5;10(11):3047. doi: 10.3390/cells10113047.
3
Could Galectin 3 Be a Good Prognostic Factor in Endometrial Cancer?半乳糖凝集素-3能否作为子宫内膜癌的良好预后因素?
Diagnostics (Basel). 2020 Aug 26;10(9):635. doi: 10.3390/diagnostics10090635.
4
Galectin-3 induced by hypoxia promotes cell migration in thyroid cancer cells.缺氧诱导的半乳糖凝集素-3促进甲状腺癌细胞的迁移。
Oncotarget. 2017 Sep 21;8(60):101475-101488. doi: 10.18632/oncotarget.21135. eCollection 2017 Nov 24.
5
Galectin-3 in angiogenesis and metastasis.半乳糖凝集素-3在血管生成与转移中的作用
Glycobiology. 2014 Oct;24(10):886-91. doi: 10.1093/glycob/cwu086. Epub 2014 Aug 18.
6
Galectin-3 and the skin.半乳糖凝集素-3 与皮肤。
J Dermatol Sci. 2011 Nov;64(2):85-91. doi: 10.1016/j.jdermsci.2011.07.008. Epub 2011 Aug 11.
7
Regulation of tumor progression by extracellular galectin-3.细胞外半乳糖凝集素-3对肿瘤进展的调控
Cancer Microenviron. 2008 Dec;1(1):43-51. doi: 10.1007/s12307-008-0003-6. Epub 2008 Feb 20.
8
Extracellular localization of galectin-3 has a deleterious role in joint tissues.半乳糖凝集素-3的细胞外定位在关节组织中具有有害作用。
Arthritis Res Ther. 2007;9(1):R20. doi: 10.1186/ar2130.
9
Galectin-3 surface expression on human adult chondrocytes: a potential substrate for collagenase-3.人成年软骨细胞上半乳糖凝集素-3的表面表达:胶原酶-3的潜在底物
Ann Rheum Dis. 2004 Jun;63(6):636-43. doi: 10.1136/ard.2003.007229.
10
Galectin-3 and metastasis.半乳糖凝集素-3与转移
Glycoconj J. 2002;19(7-9):543-9. doi: 10.1023/B:GLYC.0000014084.01324.15.